• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

Comprehensive Overview of 3-Bromo-4-ethylpyridin-2-amine (CAS No. 1381938-68-6): Properties, Applications, and Research Insights

3-Bromo-4-ethylpyridin-2-amine (CAS No. 1381938-68-6) is a specialized heterocyclic compound that has garnered significant attention in pharmaceutical and agrochemical research due to its unique molecular structure. This brominated pyridine derivative features an ethyl group at the 4-position and an amine at the 2-position, making it a versatile intermediate for synthesizing more complex molecules. Researchers and industries are increasingly exploring its potential in drug discovery, particularly for targeting enzyme inhibition and receptor modulation.

The compound's CAS No. 1381938-68-6 serves as a critical identifier in chemical databases, ensuring precise tracking in regulatory and safety documentation. Its molecular formula (C7H9BrN2) and molecular weight (201.07 g/mol) are frequently searched by chemists evaluating its reactivity or solubility profiles. Recent studies highlight its role in developing small-molecule inhibitors, aligning with the growing demand for precision medicine and targeted therapies in oncology and neurology.

In the context of green chemistry, 3-Bromo-4-ethylpyridin-2-amine is being investigated for sustainable synthesis routes. With rising interest in eco-friendly catalysts and reduced waste protocols, researchers are optimizing its production to minimize environmental impact. This aligns with global trends emphasizing ESG (Environmental, Social, and Governance) compliance in chemical manufacturing.

Another hot topic tied to this compound is its utility in high-throughput screening (HTS) platforms. As AI-driven drug discovery accelerates, CAS No. 1381938-68-6 is often included in virtual libraries for in silico modeling. Its structural motifs are valuable for designing allosteric modulators, a trending focus in GPCR (G-protein-coupled receptor) research.

From a commercial perspective, suppliers of 3-Bromo-4-ethylpyridin-2-amine emphasize its high purity grades (>98%) and custom synthesis options to meet diverse R&D needs. FAQs in search engines often revolve around its storage conditions (typically 2–8°C under inert gas) and handling precautions, reflecting user concerns about stability and shelf life.

Innovations in cryogenic reactions and flow chemistry have further expanded its applications. For instance, its bromo-ethyl synergy enables selective functionalization, a key step in creating bioconjugates for diagnostic probes. This positions the compound as a candidate for theranostic development—a fusion of therapy and diagnostics gaining traction in personalized medicine.

In summary, 3-Bromo-4-ethylpyridin-2-amine (CAS No. 1381938-68-6) exemplifies the intersection of traditional organic synthesis and cutting-edge biomedical innovation. Its adaptability to catalytic cross-coupling and relevance in fragment-based drug design ensure its continued prominence in scientific literature and industrial pipelines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)